1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Glycomic Therapeutics Market – By Class

1.3.2        North America Glycomic Therapeutics Market – By Structures

1.3.3        North America Glycomic Therapeutics Market – By Indications

1.3.4        North America Glycomic Therapeutics Market – By Mode of Action

1.3.5        North America Glycomic Therapeutics Market – By Country

2.           North America Glycomic Therapeutics Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Glycomic Therapeutics Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Expert Opinion

5.           North America Glycomic Therapeutics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Wide Application in Various Disorders Followed by the Development of New Treatment Processes

5.1.2        Increasing Research and Development In the Field of Glycomic Therapeutics

5.2         Market Restraints

5.2.1        Shortage of Skilled Professionals and Lack of Research & Development laboratories in Developing Countries.

5.3         Market Opportunities

5.3.1        Wide Applications of Glycomics in Therapeutics

5.4         Future Trends

5.4.1        New Tools in Glycomics Research

5.5         Impact Analysis

6.           Glycomic Therapeutics Market– North America Analysis

6.1         North America Glycomic Therapeutics Market Revenue Forecast and Analysis

6.1.1        North America: Glycomic Therapeutics Market, 2019-2028 (US$ Million)

7.           North America Glycomic Therapeutics Market Revenue and Forecast to 2028– by Class

7.1         Overview

7.2         North America Glycomic Therapeutics Market, By Class 2022 & 2028 (%)

7.2.1        North America: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

7.3         Isolated

7.3.1        Overview

7.3.2        North America Isolated Revenue and Forecast to 2028 (US$ Million)

7.4         Synthetic

7.4.1        Overview

7.4.2        North America Synthetic - Revenue and Forecast to 2028 (US$ Million)

8.           North America Glycomics Therapeutics Market Analysis and Forecasts To 2028 – By Indication

8.1         Overview

8.2         North America Glycomics Market, By Indication 2022 & 2028 (%)

8.2.1        North America: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

8.3         Thrombosis and Chemoprophylaxis

8.3.1        Overview

8.3.2        North America Thrombosis and chemoprophylaxis Revenue and Forecast to 2028 (US$ Million)

8.4         Anaemia

8.4.1        Overview

8.4.2        North America Anaemia Revenue and Forecast to 2028 (US$ Million)

8.5         Anti-adhesive and Anti-inflammatory

8.5.1        Overview

8.5.2        North America Anti-adhesive and Anti-inflammatory Revenue and Forecast to 2028 (US$ Million)

8.6         Cataract

8.6.1        Overview

8.6.2        North America Cataract Revenue and Forecast to 2028 (US$ Million)

8.7         Gaucher’s diseases

8.7.1        Overview

8.7.2        North America Gaucher’s diseases Revenue and Forecast to 2028 (US$ Million)

8.8         MPS-1 & IV

8.8.1        Overview

8.8.2        North America MPS-1 & IV Revenue and Forecast to 2028 (US$ Million)

8.9         Cancer

8.9.1        Overview

8.9.2        North America Cancer Revenue and Forecast to 2028 (US$ Million)

8.10      Alzheimer's

8.10.1     Overview

8.10.2     North America Alzheimer's Revenue and Forecast to 2028 (US$ Million)

8.11      Influenza Type A and B

8.11.1     Overview

8.11.2     North America Influenza Type A and B Revenue and Forecast to 2028 (US$ Million)

8.12      Others

8.12.1     Overview

8.12.2     North America Others Revenue and Forecast to 2028 (US$ Million)

9.           North America Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Structures

9.1         Overview

9.2         North America Glycomic Therapeutics Market, By Structures 2022 & 2028 (%)

9.2.1        North America: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

9.2.1.1          North America: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

9.2.1.2          North America: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

9.2.1.3          North America: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

9.2.1.4          North America: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

9.3         Glycoproteins

9.3.1        Overview

9.3.2        North America Glycoproteins - Market Revenue and Forecast to 2028 (US$ Million)

9.4         Targeting Sialic Acid

9.4.1        Overview

9.4.2        North America Targeting Sialic Acid - Market Revenue and Forecast to 2028 (US$ Million)

9.4.3        Zanamivir

9.4.3.1          Overview

9.4.3.2          North America Zanamivir - Market Revenue and Forecast to 2028 (US$ Million)

9.4.4        Oseltamivir

9.4.4.1          Overview

9.4.4.2          North America Oseltamivir - Market Revenue and Forecast to 2028 (US$ Million)

9.5         Proteoglycans

9.5.1        Overview

9.5.2        North America Proteoglycans - Market Revenue and Forecast to 2028 (US$ Million)

9.6         Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans

9.6.1        Overview

9.6.2        North America Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecast to 2028 (US$ Million)

9.7         Targeting Glycosaminoglycans

9.7.1        Overview

9.7.2        North America Targeting Glycosaminoglycans - Market Revenue and Forecast to 2028 (US$ Million)

9.7.3        Heparin

9.7.3.1          Overview

9.7.3.2          North America Heparin - Market Revenue and Forecast to 2028 (US$ Million)

9.7.4        Hyaluronan (HA)

9.7.4.1          Overview

9.7.4.2          North America Hyaluronan (HA)- Market Revenue and Forecast to 2028 (US$ Million)

9.7.5        Laronidase

9.7.5.1          Overview

9.7.5.2          North America Laronidase - Market Revenue and Forecast to 2028 (US$ Million)

9.7.6        Galsulfase (Naglazyme)

9.7.6.1          Overview

9.7.6.2          North America Galsulfase (Naglazyme) - Market Revenue and Forecast to 2028 (US$ Million)

9.7.7        Hyaluronidase (Cumulase)

9.7.7.1          Overview

9.7.7.2          North America Hyaluronidase (Cumulase) - Market Revenue and Forecast to 2028 (US$ Million)

9.7.8        Others

9.7.8.1          Overview

9.7.8.2          North America Others - Market Revenue and Forecast to 2028 (US$ Million)

9.8         Targeting Glycosphingolipids

9.8.1        Overview

9.8.2        North America Targeting Glycosphingolipids - Market Revenue and Forecast to 2028 (US$ Million)

9.8.3        Imiglucerase (Cerezyme)

9.8.3.1          Overview

9.8.3.2          North America Imiglucerase (Cerezyme)- Market Revenue and Forecast to 2028 (US$ Million)

9.8.3.3          Agalsidase (Fabrazyme)

9.8.3.3.1          Overview

9.8.3.3.2          North America Agalsidase (Fabrazyme) - Market Revenue and Forecast to 2028 (US$ Million)

9.8.3.4          N-butyl-deoxynojirimycin (DNJ)

9.8.3.4.1          Overview

9.8.3.4.2          North America N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecast to 2028 (US$ Million)

9.8.4        Others

9.8.4.1          Overview

9.8.4.2          North America Others - Market Revenue and Forecast to 2028 (US$ Million)

9.9         Others

9.9.1        Overview

9.9.2        North America Others - Market Revenue and Forecast to 2028 (US$ Million)

9.9.3        Acarbose

9.9.3.1          Overview

9.9.3.2          North America Acarbose - Market Revenue and Forecast to 2028 (US$ Million)

9.9.3.3          Alglucosidase Alfa (Myozyme)

9.9.3.3.1          Overview

9.9.3.3.2          North America Alglucosidase Alfa (Myozyme) - Market Revenue and Forecast to 2028 (US$ Million)

9.9.3.4          Allosamidin

9.9.3.4.1          Overview

9.9.3.4.2          North America Allosamidin - Market Revenue and Forecast to 2028 (US$ Million)

9.9.4        Others

9.9.4.1          Overview

9.9.4.2          North America Others - Market Revenue and Forecast to 2028 (US$ Million)

10.        North America Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Mode of Action

10.1      Overview

10.2      North America Glycomic Therapeutics Market, By Mode of Action 2022 & 2028 (%)

10.2.1     North America: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

10.3      Inhibits Neuraminidase

10.3.1     Overview

10.3.2     North America Inhibits Neuraminidase - Market Revenue and Forecast to 2028 (US$ Million)

10.4      Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate

10.4.1     Overview

10.4.2     North America Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecast to 2028 (US$ Million)

10.5      Erythropoietin And Enzyme Replacement Therapy (ERT)

10.5.1     Overview

10.5.2     North America Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecast to 2028 (US$ Million)

10.6      Tissue Plasminogen Activator

10.6.1     Overview

10.6.2     North America Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)

10.7      Inhibits Glucosylceramide Synthase

10.7.1     Overview

10.7.2     North America Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)

10.8      Interleukin 1 And 2 And 3

10.8.1     Overview

10.8.2     North America Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)

10.9      Beta And Gamma Interferons

10.9.1     Overview

10.9.2     North America Beta And Gamma Interferons- Market Revenue And Forecasts To 2028 (US$ Million)

10.10   Others

10.10.1  Overview

10.10.2  North America Others- Market Revenue And Forecasts To 2028 (US$ Million)

11.        North America Glycomic Therapeutics Market Revenue and Forecasts to 2028 – Country Analysis

11.1      North America: Glycomic Therapeutics Market

11.1.1     Overview

11.1.2     North America: Glycomic Therapeutics Market, by Country, 2021 & 2028 (%)

11.1.3     US: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.1       Overview

11.1.3.1.2       US: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.1.3       US: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

11.1.3.1.4       US: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

11.1.3.1.4.1    US: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

11.1.3.1.4.2    US: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

11.1.3.1.4.3    US: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

11.1.3.1.4.4    US: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

11.1.3.1.5       US: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

11.1.3.1.6       US: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

11.1.3.2       Canada: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.1       Overview

11.1.3.2.2       Canada: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.2.3       Canada: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

11.1.3.2.4       Canada: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

11.1.3.2.4.1    Canada: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

11.1.3.2.4.2    Canada: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

11.1.3.2.4.3    Canada: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

11.1.3.2.4.4    Canada: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

11.1.3.2.5       Canada: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

11.1.3.2.6       Canada: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

11.1.3.3       Mexico: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.1       Overview

11.1.3.3.2       Mexico: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

11.1.3.3.3       Mexico: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)

11.1.3.3.4       Mexico: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)

11.1.3.3.4.1    Mexico: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)

11.1.3.3.4.2    Mexico: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)

11.1.3.3.4.3    Mexico: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)

11.1.3.3.4.4    Mexico: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)

11.1.3.3.5       Mexico: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)

11.1.3.3.6       Mexico: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)

12.        Glycomic Therapeutics Market –Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Glycomic Therapeutics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      BioMarin Pharmaceutical Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Genzyme Corporation (Sanofi)

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Halozyme Therapeutics, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bayer AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Alzheon, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      GlaxoSmithKline plc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      F. Hoffmann-La Roche Ltd

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms in Glycomic Therapeutics Market

LIST OF TABLES

Table 1.             North America Glycomic Therapeutics Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             North America Glycomic Therapeutics Market, by C lass – Revenue and Forecast to 2028 (US$ Million)

Table 3.             North America Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4.             North America Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)

Table 5.             North America Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)

Table 6.             North America Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)

Table 7.             North America Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)

Table 8.             North America Glycomic Therapeutics Market, by Others– Revenue and Forecast to 2028 (USD Million)

Table 9.             North America Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)

Table 10.          US Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (USD Million)

Table 11.          US Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)

Table 12.          US Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)

Table 13.          US Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)

Table 14.          US Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)

Table 15.          US Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (USD Million)

Table 16.          US Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          US Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)

Table 18.          Canada Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (USD Million)

Table 19.          Canada Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)

Table 20.          Canada Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)

Table 21.          Canada Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)

Table 22.          Canada Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)

Table 23.          Canada Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (USD Million)

Table 24.          Canada Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 25.          Canada Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)

Table 26.          Mexico Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Mexico Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Mexico Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Mexico Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Mexico Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Mexico Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Mexico Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Mexico Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Organic Developments in the Glycomic Therapeutics Market

Table 35.          Inorganic Developments in the Glycomic Therapeutics Market

Table 36.          Glossary of Terms in Glycomic Therapeutics Market

LIST OF FIGURES

Figure 1.           North America Glycomic Therapeutics Market Segmentation

Figure 2.           North America Glycomic Therapeutics Market, By Country

Figure 3.           North America Glycomic Therapeutics Market Overview

Figure 4.           Synthetic Segment Held Largest Share of Class Segment in North America Glycomic Therapeutics Market

Figure 5.           Canada is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           North America Glycomic Therapeutics Market Impact Analysis of Driver and Restraints

Figure 8.           North America Glycomics market – Revenue Forecast And Analysis – 2020- 2028

Figure 9.           North America Glycomic Therapeutics Market, by Class 2022 & 2028 (%)

Figure 10.        North America Isolated Revenue and Forecasts to 2028 (US$ Million)

Figure 11.        North America Synthetic - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        North America Glycomics Market, by Indication 2022 & 2028 (%)

Figure 13.        North America Thrombosis and chemoprophylaxis Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        North America Anaemia Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        North America Anti-adhesive and Anti-inflammatory Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        North America Cataract Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        North America Gaucher’s diseases Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        North America MPS-1 & IV Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        North America Cancer Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        North America Alzheimer's Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        North America Influenza Type A and B Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        North America Others Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        North America Glycomic Therapeutics Market, by Structures 2022 & 2028 (%)

Figure 24.        North America Glycoproteins - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        North America Targeting Sialic Acid - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        North America Zanamivir - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        North America Oseltamivir - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        North America Proteoglycans - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        North America Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        North America Targeting Glycosaminoglycans - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 31.        North America Heparin - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 32.        North America Hyaluronan (HA) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 33.        North America Laronidase - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 34.        North America Galsulfase (Naglazyme) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 35.        North America Hyaluronidase (Cumulase) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 36.        North America Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 37.        North America Targeting Glycosphingolipids - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 38.        North America Imiglucerase (Cerezyme) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 39.        North America Agalsidase (Fabrazyme) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 40.        North America N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 41.        North America Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 42.        North America Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 43.        North America Acarbose - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 44.        North America Alglucosidase Alfa (Myozyme) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 45.        North America Allosamidin - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 46.        North America Others - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 47.        North America Glycomic Therapeutics Market, by Mode of Action 2022 & 2028 (%)

Figure 48.        North America Inhibits Neuraminidase - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 49.        North America Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 50.        North America Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 51.        North America Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 52.        North America Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 53.        North America Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)

Figure 54.        North America Beta And Gamma Interferons - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 55.        North America Others - Market Revenue And Forecasts To 2028 (US$ Million)

Figure 56.        North America: Glycomic Therapeutics Market, by Key Country – Revenue (2022) (US$ Million)

Figure 57.        North America: Glycomic Therapeutics Market, by Country, 2021 & 2028 (%)

Figure 58.        US: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59.        Canada: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 60.        Mexico: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 61.        Growth Strategies in the Glycomic Therapeutics Market (%)